{
    "Trade/Device Name(s)": [
        "Triage\u00ae TOX Drug Screen"
    ],
    "Submitter Information": "Biosite Incorporated",
    "510(k) Number": "K060791",
    "Predicate Device Reference 510(k) Number(s)": [
        "K973784",
        "K043242"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJR"
    ],
    "Summary Letter Date": "June 22, 2006",
    "Summary Letter Received Date": "June 9, 2006",
    "Submission Date": "June 6, 2006",
    "Regulation Number(s)": [
        "21 CFR\u00a7862.3620"
    ],
    "Regulation Name(s)": [
        "Methadone test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Acetaminophen/Paracetamol",
        "Amphetamines",
        "Methamphetamines",
        "Barbiturates",
        "Benzodiazepines",
        "Cocaine",
        "Methadone",
        "Opiates",
        "Phencyclidine",
        "THC",
        "Tricyclic Antidepressants"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Triage MeterPlus",
        "Triage Meters"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Biosite Triage TOX Drug Screen, a fluorescence immunoassay for qualitative detection of multiple drugs and metabolites in urine using the Triage Meters.",
    "Indications for Use Summary": "Qualitative point-of-care fluorescence immunoassay for detecting presence of up to 10 drug classes, including acetaminophen/paracetamol, amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, methadone, opiates, phencyclidine, THC, and tricyclic antidepressants in urine.",
    "fda_folder": "Toxicology"
}